XT
LEGN icon

XTX Topco’s Legend Biotech LEGN Stock Holding History

XTX Topco’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.54M Sell
88,106
-120,101
-58% -$3.24M 0.03% 880
2026
Q1 		$3.77M Buy
+208,207
New +$3.97M 0.07% 441
2025
Q2 		– Sell
-9,045
Closed -$307K – 2814
2025
Q1 		$307K Buy
+9,045
New +$324K 0.02% 1390
2024
Q4 		– Sell
-37,769
Closed -$1.84M – 2645
2024
Q3 		$1.84M Buy
+37,769
New +$2.01M 0.13% 171
2023
Q4 		– Sell
-10,850
Closed -$729K – 1869
2023
Q3 		$729K Buy
10,850
+4,073
+60% +$283K 0.12% 207
2023
Q2 		$468K Buy
+6,777
New +$443K 0.08% 411

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

XTX Topco's LEGN Position: Q2 2026 in Review

XTX Topco reduced its Legend Biotech (LEGN) stake by 58% in Q2 2026, selling an estimated $3.24M and leaving 88,106 shares worth $2.54M. The position accounts for 0.03% of the portfolio, ranked #880.

XTX Topco first reported a position in LEGN in Q2 2023 and has held it in 6 quarters since. The position peaked at $3.77M in Q1 2026. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • XTX Topco held 88,106 shares of Legend Biotech worth $2.54M as of Q2 2026.
  • XTX Topco sold 120,101 Legend Biotech shares in Q2 2026, an estimated $3.24M.
  • Legend Biotech made up 0.03% of XTX Topco's portfolio in Q2 2026, its #880 holding.
  • XTX Topco first reported a position in Legend Biotech in Q2 2023 and has held it in 6 quarters since.
  • XTX Topco's Legend Biotech position peaked at $3.77M in Q1 2026.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.